HK Stock MarketDetailed Quotes

02696 HENLIUS

Watchlist
  • 23.900
  • 0.0000.00%
Market Closed Dec 27 16:08 CST
12.99BMarket Cap17.12P/E (TTM)

HENLIUS Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
Turnover
9.82%2.75B
67.82%5.39B
--3.93B
93.93%2.5B
91.07%3.21B
103.50%1.29B
186.34%1.68B
473.95%633.6M
546.20%587.59M
547.88%110.39M
Operating income
9.82%2.75B
67.82%5.39B
3.93B
93.93%2.5B
91.07%3.21B
103.50%1.29B
186.34%1.68B
473.95%633.6M
546.20%587.59M
547.88%110.39M
Cost of sales
-4.68%-755.41M
-74.77%-1.48B
---1.13B
-136.13%-721.64M
-61.57%-844.62M
-38.02%-305.61M
-187.04%-522.75M
-279.35%-221.42M
-153.57%-182.12M
-416.71%-58.37M
Operating expenses
-4.68%-755.41M
-74.77%-1.48B
-1.13B
-136.13%-721.64M
-61.57%-844.62M
-38.02%-305.61M
-187.04%-522.75M
-279.35%-221.42M
-153.57%-182.12M
-416.71%-58.37M
Gross profit
11.91%1.99B
65.34%3.92B
2.8B
80.82%1.78B
104.37%2.37B
138.68%983.79M
186.02%1.16B
692.27%412.18M
2,021.98%405.47M
805.89%52.03M
Selling expenses
-14.98%-900.22M
-67.18%-1.75B
---1.23B
-106.78%-782.95M
-101.69%-1.05B
-91.88%-378.64M
-113.53%-520.26M
-248.78%-197.33M
-433.27%-243.65M
-338.24%-56.58M
Administrative expenses
2.30%-159.95M
-8.42%-383.84M
---260.17M
-1.98%-163.71M
-26.17%-354.04M
-35.70%-160.54M
-45.66%-280.61M
-87.19%-118.3M
-10.18%-192.64M
4.32%-63.2M
Research and development expenses
11.93%-482.47M
19.78%-1.12B
---817.6M
-2.49%-547.83M
-36.19%-1.39B
-18.30%-534.5M
-14.52%-1.02B
-14.97%-451.81M
-47.11%-894.14M
-74.53%-392.98M
Impairment and provision
----
84.92%-30.28M
---22.27M
32.50%-729K
-115,297.13%-200.79M
-386.49%-1.08M
-1,342.86%-174K
48.49%-222K
100.26%14K
---431K
-Other impairment is provision
----
84.92%-30.28M
---22.27M
32.50%-729K
-115,297.13%-200.79M
-386.49%-1.08M
-1,342.86%-174K
48.49%-222K
100.26%14K
---431K
Special items of operating profit
-27.46%10.45M
20.10%48.41M
--27.26M
113.23%14.41M
119.50%40.31M
-6,717.01%-108.92M
-730.51%-206.67M
-94.47%1.65M
-108.05%-24.89M
946.19%29.76M
Operating profit
53.85%458.51M
215.62%680.12M
494.3M
249.09%298.02M
32.54%-588.22M
43.51%-199.89M
8.20%-871.92M
17.98%-353.85M
-14.92%-949.84M
-45.97%-431.4M
Financing cost
-16.11%-62.8M
-4.61%-110.54M
---82.55M
-5.52%-54.08M
-24.58%-105.67M
-28.16%-51.26M
-94.07%-84.82M
-141.10%-39.99M
9.53%-43.71M
22.48%-16.59M
Earning before tax
62.22%395.72M
182.09%569.58M
411.75M
197.13%243.94M
27.47%-693.89M
36.23%-251.14M
3.70%-956.74M
12.09%-393.84M
-13.57%-993.54M
-41.35%-447.98M
Tax
-138.04%-9.42M
-1,617.13%-23.56M
---3.96M
-315.11%-3.96M
94.98%-1.37M
---953K
---27.31M
----
----
----
After-tax profit from continuing operations
60.97%386.3M
178.53%546.02M
407.8M
195.19%239.98M
29.35%-695.26M
35.99%-252.1M
0.96%-984.05M
12.09%-393.84M
-13.49%-993.54M
-41.35%-447.98M
Earning after tax
60.97%386.3M
178.53%546.02M
407.8M
195.19%239.98M
29.35%-695.26M
35.99%-252.1M
0.96%-984.05M
12.09%-393.84M
-13.49%-993.54M
-41.35%-447.98M
Profit attributable to shareholders
60.97%386.3M
178.53%546.02M
407.8M
195.19%239.98M
29.35%-695.26M
35.99%-252.1M
0.96%-984.05M
12.09%-393.84M
-13.49%-993.54M
-41.35%-447.98M
Basic earnings per share
61.36%0.71
178.91%1.01
0.75
193.62%0.44
30.05%-1.28
35.62%-0.47
2.66%-1.83
14.12%-0.73
-6.82%-1.88
-21.43%-0.85
Diluted earnings per share
61.36%0.71
178.13%1
0.75
193.62%0.44
30.05%-1.28
35.62%-0.47
2.66%-1.83
14.12%-0.73
-6.82%-1.88
-21.43%-0.85
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
--
Ernst & Young
--
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020
Turnover 9.82%2.75B67.82%5.39B--3.93B93.93%2.5B91.07%3.21B103.50%1.29B186.34%1.68B473.95%633.6M546.20%587.59M547.88%110.39M
Operating income 9.82%2.75B67.82%5.39B3.93B93.93%2.5B91.07%3.21B103.50%1.29B186.34%1.68B473.95%633.6M546.20%587.59M547.88%110.39M
Cost of sales -4.68%-755.41M-74.77%-1.48B---1.13B-136.13%-721.64M-61.57%-844.62M-38.02%-305.61M-187.04%-522.75M-279.35%-221.42M-153.57%-182.12M-416.71%-58.37M
Operating expenses -4.68%-755.41M-74.77%-1.48B-1.13B-136.13%-721.64M-61.57%-844.62M-38.02%-305.61M-187.04%-522.75M-279.35%-221.42M-153.57%-182.12M-416.71%-58.37M
Gross profit 11.91%1.99B65.34%3.92B2.8B80.82%1.78B104.37%2.37B138.68%983.79M186.02%1.16B692.27%412.18M2,021.98%405.47M805.89%52.03M
Selling expenses -14.98%-900.22M-67.18%-1.75B---1.23B-106.78%-782.95M-101.69%-1.05B-91.88%-378.64M-113.53%-520.26M-248.78%-197.33M-433.27%-243.65M-338.24%-56.58M
Administrative expenses 2.30%-159.95M-8.42%-383.84M---260.17M-1.98%-163.71M-26.17%-354.04M-35.70%-160.54M-45.66%-280.61M-87.19%-118.3M-10.18%-192.64M4.32%-63.2M
Research and development expenses 11.93%-482.47M19.78%-1.12B---817.6M-2.49%-547.83M-36.19%-1.39B-18.30%-534.5M-14.52%-1.02B-14.97%-451.81M-47.11%-894.14M-74.53%-392.98M
Impairment and provision ----84.92%-30.28M---22.27M32.50%-729K-115,297.13%-200.79M-386.49%-1.08M-1,342.86%-174K48.49%-222K100.26%14K---431K
-Other impairment is provision ----84.92%-30.28M---22.27M32.50%-729K-115,297.13%-200.79M-386.49%-1.08M-1,342.86%-174K48.49%-222K100.26%14K---431K
Special items of operating profit -27.46%10.45M20.10%48.41M--27.26M113.23%14.41M119.50%40.31M-6,717.01%-108.92M-730.51%-206.67M-94.47%1.65M-108.05%-24.89M946.19%29.76M
Operating profit 53.85%458.51M215.62%680.12M494.3M249.09%298.02M32.54%-588.22M43.51%-199.89M8.20%-871.92M17.98%-353.85M-14.92%-949.84M-45.97%-431.4M
Financing cost -16.11%-62.8M-4.61%-110.54M---82.55M-5.52%-54.08M-24.58%-105.67M-28.16%-51.26M-94.07%-84.82M-141.10%-39.99M9.53%-43.71M22.48%-16.59M
Earning before tax 62.22%395.72M182.09%569.58M411.75M197.13%243.94M27.47%-693.89M36.23%-251.14M3.70%-956.74M12.09%-393.84M-13.57%-993.54M-41.35%-447.98M
Tax -138.04%-9.42M-1,617.13%-23.56M---3.96M-315.11%-3.96M94.98%-1.37M---953K---27.31M------------
After-tax profit from continuing operations 60.97%386.3M178.53%546.02M407.8M195.19%239.98M29.35%-695.26M35.99%-252.1M0.96%-984.05M12.09%-393.84M-13.49%-993.54M-41.35%-447.98M
Earning after tax 60.97%386.3M178.53%546.02M407.8M195.19%239.98M29.35%-695.26M35.99%-252.1M0.96%-984.05M12.09%-393.84M-13.49%-993.54M-41.35%-447.98M
Profit attributable to shareholders 60.97%386.3M178.53%546.02M407.8M195.19%239.98M29.35%-695.26M35.99%-252.1M0.96%-984.05M12.09%-393.84M-13.49%-993.54M-41.35%-447.98M
Basic earnings per share 61.36%0.71178.91%1.010.75193.62%0.4430.05%-1.2835.62%-0.472.66%-1.8314.12%-0.73-6.82%-1.88-21.43%-0.85
Diluted earnings per share 61.36%0.71178.13%10.75193.62%0.4430.05%-1.2835.62%-0.472.66%-1.8314.12%-0.73-6.82%-1.88-21.43%-0.85
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion--------Unqualified Opinion--Unqualified Opinion--
Auditor --Ernst & Young----Ernst & Young--Ernst & Young--Ernst & Young--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
HK
Overall
Symbol
Price
% Chg

No Data

Investment Theme Biotechnology
Biotechnology
Intraday-1.59%